Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors
Purpose. To evaluate the role of the activation of mTOR (phosphorylated mTOR, p-mTOR) and the expression SSTR2A and IGF-1R as prognostic factor in well-differentiated neuroendocrine tumors. Methods. A retrospective study was conducted on data from patients with diagnosis of neuroendocrine tumor orig...
Saved in:
Main Authors: | G. Lamberti, C. Ceccarelli, N. Brighi, I. Maggio, D. Santini, C. Mosconi, C. Ricci, G. Biasco, D. Campana |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/7872519 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Bone Loss with the Upregulation of Survival-Related Genes and Concomitant Downregulation of Mammalian Target of Rapamycin and Osteoblast Differentiation-Related Genes in the Peripheral Blood of Late Postmenopausal Osteoporotic Women
by: Elena V. Tchetina, et al.
Published: (2015-01-01) -
Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis
by: S. I. Mozgovoi, et al.
Published: (2020-01-01) -
Effect of 25-hydroxycholecalciferol and high phytase doses on performance, vitamin D status, bone mineralization, and mechanistic target of rapamycin gene expression of broilers
by: L.S. Bassi, et al.
Published: (2025-02-01) -
Exploring the interactions of rapamycin with target receptors in A549 cancer cells: insights from molecular docking analysis
by: Sanjeev K. Ganesh, et al.
Published: (2025-01-01) -
Prognostic Impact of DNA-Image-Cytometry in Neuroendocrine (Carcinoid) Tumours
by: H. Raatz, et al.
Published: (2004-01-01)